Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

ProBioGen and Lava Therapeutics Sign Cell Line Development and GMP Manufacturing Agreement for Novel Bispecific Molecule

b3cnewswireJanuary 16, 2020

Tag: ProBioGen , Lava , GMP manufacturing , Cell

PharmaSources Customer Service